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Three human hyaluronan synthase genes (HAS1,
HAS2, and HAS3) have been cloned, but the func-
tional differences between these HAS genes remains
obscure. The purpose of this study was to examine
which of the HAS genes are selectively regulated in
epidermis. We examined the relation of changes
between hyaluronan production and HAS gene
expression when cytokines were added to cultured
human keratinocytes. Interferon-g increased hyaluro-
nan production whereas transforming growth factor
b decreased it. Both cytokines affected preferentially
high-molecular-mass (> 106 Da) hyaluronan produc-
tion. Consistent with the change in hyaluronan syn-
thesis, we found that interferon-g markedly
upregulated HAS3 mRNA whereas transforming
growth factor b downregulated HAS3 transcript
levels. The expression of HAS1 mRNA was not sig-
ni®cantly affected by either cytokine, and HAS2
mRNA expression was undetectable under either
basal or cytokine-stimulated conditions by northern
blot using total RNA. Furthermore, in situ mRNA
hybridization showed that mouse epidermal kerati-
nocytes abundantly expressed HAS3 mRNA from the
basal to the granular cell layers, suggesting that
HAS3 functions in epidermis. These ®ndings suggest
that HAS3 gene expression plays a crucial role in the
regulation of hyaluronan synthesis in the epidermis.
Key words: HAS1/HAS2/HAS3/IFN-g/TGF-b. J Invest
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H
yaluronan, a high-molecular-weight linear glycosa-
minoglycan consisting of alternating glucuronic acid
and N-acetylglucosamine residues, is found in the
extracellular matrix (Laurent and Fraser, 1992). In
the skin, hyaluronan was previously thought to
derive exclusively from dermis. Histologic staining techniques,
however, later revealed that hyaluronan can also be found around
keratinocytes in the epidermis (Tammi et al, 1988). Moreover, we
have recently shown that hyaluronan can be found not only in the
basal to the spinous layer, but also in the stratum corneum (Sakai et al,
2000). These ®ndings strongly suggest that keratinocytes themselves
synthesize the epidermal hyaluronan.
Accumulation of hyaluronan is correlated with cell proliferation
and migration in several developing tissues and organs (Brecht et al,
1986; Chen et al, 1989), but the functions of epidermal hyaluronan
are not well known. Previous studies showed that retinoic acid, an
inhibitor of epidermal differentiation, leads to the accumulation of
hyaluronan in the epidermal intercellular space (Tammi et al, 1989),
and also that hydrocortisone, an agent widely used in the treatment
of skin diseases as an antiproliferative or aniti-in¯ammatory, inhibits
epidermal hyaluronan synthesis at pharmacologic doses (AÊ gren et al,
1995). In psoriasis, characterized by enhanced epidermal prolifer-
ation, hyaluronan accumulates abundantly in the basal cell layer
(Wells et al, 1991). These ®ndings indicate that hyaluronan is
closely involved in keratinocyte proliferation and differentiation,
and hence may participate in epidermal structure and turnover.
Molecular cloning of genes encoding hyaluronan synthase is one
of the essential steps to investigate the biologic functions of
hyaluronan. Recently, several putative mammalian hyaluronan
synthases (HAS) have been identi®ed and cloned. These HAS
genes, HAS1 (Itano and Kimata, 1996a; 1996b; Shyjan et al, 1996),
HAS2 (Spicer et al, 1996; Watanabe and Yamaguchi, 1996), and
HAS3 (Spicer et al, 1997), encode predicted plasma membrane
proteins with multiple transmembrane domains. The expression of
any one HAS gene in transfected mammalian cells leads to high
levels of hyaluronan biosynthesis. In a previous study, our group
found that human skin ®broblasts abundantly express HAS1 and
HAS2 mRNA, and that transforming growth factor b (TGF-b)
upregulates the expression of both of these HAS genes (Sugiyama et
al, 1998). Whereas the cytokines TGF-b, platelet-derived growth
factor (Heldin et al, 1989; Suzuki et al, 1995), interferon g (IFN-g),
tumor necrosis factor a (TNF-a) (Elias et al, 1988), interleukin-1
(IL-1) (Postlethwaite et al, 1989), and epidermal growth factor
(EGF) (Hata et al, 1988) have been shown to stimulate ®broblast
hyaluronan synthesis, the cytokines regulating keratinocyte hyalur-
onan synthesis have not been adequately investigated.
The purpose of this study was to examine which of the HAS
genes are selectively regulated in epidermis by cytokines. We
examined HAS gene expression and changes in the quality and
quantity of the hyaluronan synthesized in cultured human
keratinocytes stimulated with cytokines whose receptors are
expressed in keratinocytes, namely, IFN-g, TGF-b, IL-1a, TNF-
a, IL-8, and IL-10.
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MATERIALS AND METHODS
Materials Normal human foreskin keratinocytes and bovine pituitary
extract were purchased from Kurabo (Osaka, Japan), and male hairless
mice (Hos/HR-1) were from SLC (Shizuoka, Japan). MCDB153
medium, calcium ionophore A23187, and insulin were purchased from
Wako Pure Chemical Industries (Osaka, Japan). EGF was purchased
from Sigma (St. Louis, MO), hydrocortisone from Merck (Darmstadt,
Germany), 2-aminoethanol from Nacalai Tesque (Kyoto, Japan), and O-
phosphorylethanolamine from Tokyo Kasei (Tokyo, Japan).
Recombinant human IFN-g and TGF-b were obtained from R&D
Systems (Minneapolis, MN), and IL-1a, TNF-a, IL-8, and IL-10 from
Intergen (Boston, MA). Eagle's minimal essential medium was purchased
from ICN Biomedicals (Costa Mesa, CA) and fetal bovine serum from
Irvine Scienti®c (Santa Ana, CA). Superscript II was purchased from
Gibco BML (Rockville, MD), and the GeneAmp PCR Kit was from
Perkin-Elmer (Norwalk, CT). Digoxigenin (DIG) RNA labeling kit,
DIG nucleic acid detection kit, anti-DIG alkaline phosphatase conjugate,
and positively charged nylon membrane were from Roche (Tokyo,
Japan), RNaid Kit was from Biol01 (Vista, CA), and human
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA was from
Clontech (Palo Alto, CA). Oligotex-dT30 was obtained from Takara
Shuzou (Kyoto, Japan). Hyaluronidase derived from Streptomyces
hyalurolyticus was purchased from Seikagaku (Tokyo, Japan), and
Streptomyces griseus pronase from Calbiochem-Novabiochem (La Jolla,
CA). D-[1,6-3H(N)]glucosamine hydrochloride (62 Ci per mmol) was
obtained from NEN Research Products (Boston, MA), Sephadex G-50
and Sepharose CL-2B from Pharmacia (Uppsala, Sweden), and the DE-
52 from Whatman (Maidstone, England). Chugai hyaluronan plate was
obtained from Chugai Diagnostics Science (Tokyo, Japan).
Cell culture Human epidermal keratinocytes were routinely grown in
MCDB153 (0.1 mM Ca2+) supplemented with 5 mg per liter insulin,
180 mg per liter hydrocortisone, 14.1 mg per liter O-
phosphorylethanolamine, 6.1 mg per liter 2-aminoethanol, 100 ng per
liter EGF, and 0.4% (vol/vol) bovine pituitary extract. The culture
medium was changed every 2 d. Once the cells had become
subcon¯uent, they were subcultured in 24-well plates (1.0 3 104 cells
per well) or in 90 mm dishes (4.0 3 105 cells per dish) in the same
medium. After subculturing for 5 d, cells were con¯uent and the
medium was exchanged for an identical medium but without EGF and
bovine pituitary extract. At 24 h after the medium change, each cytokine
was added to the medium and cultured. The 18-h conditioned media of
the 24-well plates were assayed for hyaluronan synthesis and production,
and total RNA extracted from the cells treated with cytokines for 6 h in
the 90 mm dishes was examined by northern blot analysis.
Human skin ®broblast Detroit 551 (ATCC CCL110) cells were seeded
in Eagle's minimal essential medium supplemented with 10% fetal bovine
serum in 225 cm2 plastic tissue culture ¯asks (2.0 3 106 cells per dish).
After culturing for 4 d, cells were con¯uent and poly(A)+ RNA was
extracted from the cells.
Corni®ed envelope formation of keratinocytes was estimated by the
method described previously (Shimada et al, 1998). Brie¯y, keratinocytes
from the 24-well plates were harvested with 0.5 mM ethylenediamine
tetraacetic acid and 0.25% trypsin and then divided into two fractions.
One aliquot was resuspended in medium and the total number of cells
was counted in a hemocytometer. A second aliquot was resuspended in
medium containing 1.2 mM calcium and treated with 20 mM calcium
ionophore at 37°C for 2 h followed by boiling in 2% sodium dodecyl
sulfate (SDS)/20 mM dithiothreitol solution at 100°C for 5 min. The
number of remaining cells, which were resistant to SDS because of their
corni®ed envelope formation, was counted.
Assay of hyaluronan synthesis and content IFN-g (1.0±30 ng per
ml), TGF-b (0.3±10 ng per ml), IL-1a (10 ng per ml), TNF-a (10 ng
per ml), IL-8 (10 ng per ml), or IL-10 (10 ng per ml) was added to the
cells in the 24-well plates and the cultures were incubated for 18 h with
[3H]glucosamine (10 mCi per ml). After incubation, we estimated the
hyaluronan synthesis in the conditioned media by measuring the
radioactivity of the Streptomyces hyaluronidase-sensitive materials as
described previously (Sakai et al, 1999). Brie¯y, the culture media were
harvested and treated with pronase (30 mg per ml). The pronase-treated
solution was divided into two parts, one for digestion by Streptomyces
hyaluronidase (1.5 TRU per ml) and the other left untreated as a
control. The reaction mixtures were subjected to gel chromatography on
a Sephadex G-50 column (1.5 3 5 cm), and void fractions were
collected and measured for radioactivity.
Hyaluronan production in culture supernatants was measured with a
Chugai hyaluronan plate. This kit is based on the speci®city of a
hyaluronan-binding protein isolated from bovine cartilage for hyaluronan
(Kondo et al, 1991).
Molecular mass distribution of labeled hyaluronan Pronase-treated
conditioned media were applied to a DE-52 ion-exchange column
(1.0 3 12 cm) equilibrated with 10 mM Tris±HCl (pH 8.4). Each
column was washed with 10 ml of the equilibration buffer and then
eluted with an NaCl gradient (0±0.6 M) in the 10 mM Tris±HCl.
Fractions of 2 ml were collected, and aliquots were measured for
radioactivity. The puri®ed hyaluronan was identi®ed by a change in
elution position during Sephadex G-50 gel chromatography after
treatment of the second aliquots with Streptomyces hyaluronidase. The
fractions of the DE-52 column containing hyaluronan were pooled, a
single aliquot (1.0 ml) from these pooled fractions was used for the
molecular mass determination on a Sepharose CL-2B column
(1.0 3 55 cm) eluted with 1.0 M NaCl, and 2.5 ml fractions were
collected and counted for radioactivity.
HAS3 cDNA isolation Human HAS1 and HAS2 cDNA isolations
were described previously (Sugiyama et al, 1998). The cDNA of mouse
and human HAS3 genes were generated using reverse transcription
polymerase chain reaction (RT-PCR) and a second PCR. The following
primers were designed for RT-PCR: for mouse HAS3, sense primer 5¢-
ACTGCCTTCAAGGCCCTTGG-3¢ and antisense primer 5¢-
AATGTTCCAGATGCGGCCAC-3¢; for human HAS3, sense primer
5¢-GGAAAGCTTGGCATGTACCGCAACAG-3¢ and antisense primer
5¢-AGAGGAGGGAGTAGAGGGAC-3¢ (Spicer et al, 1997). Total
RNA from human keratinocytes for human HAS3 and mouse skin for
mouse HAS3 were used for RT-PCR. PCR consisted of 30 cycles of
denaturation at 94°C for 1 min, annealing at 60°C for 2 min, and
elongation at 72°C for 2 min. The expected cDNA fractions were used
as templates for the second PCR. The following primers were designed
for the second PCR: for mouse HAS3, sense primer 5¢-
GGAAAGCTTGACTCTGACACTGTGC-3¢ and antisense primer 5¢-
AGGGAATTCTGTAGAGCCATTCCCG-3¢; for human HAS3, sense
primer 5¢-GGAAAGCTTGGCATGTACCGCAACAG-3¢ and antisense
primer 5¢-AGGGAATTCGGAAGCAGGCGTAGGTG-3¢. The under-
lined sequences correspond to the restriction sites for HindIII/EcoRI.
The isolated cDNA was digested with HindIII/EcoRI and then ligated
into the HindIII/EcoRI site of pSPT18 (Roche). The nucleotide
sequences of isolated cDNA were con®rmed to be the authentic HAS3
cDNA sequences by sequencing. DIG-labeled antisense/sense RNA
probes were prepared from isolated cDNA using a DIG RNA labeling
kit.
Northern blot analysis Total RNA or poly(A)+ RNA samples
prepared from cells were separated by electrophoresis on 0.8%
formaldehyde/agarose gel and transferred to a nylon membrane. DIG-
labeled HAS3 antisense RNA probes were prepared as described above.
Hybridization was performed according to the protocol in the DIG
Nucleic Acid Detection Kit. The chemiluminescent detection was
performed as described previously (Engler-Blum et al, 1993). The
membranes were washed at 95°C for 3 min in 0.1% SDS, cooled to
room temperature, and rehybridized with a DIG-labeled GAPDH
antisense RNA probe.
In situ mRNA hybridization In situ mRNA hybridization was
performed as described previously (Shimada et al, 1998). Skin-tissue
sections from 10-wk-old, male, hairless Hos/HR mice were used.
DIG-labeled mouse HAS3 antisense RNA probes (®nal concentration,
1 mg per ml) were used to detect HAS3 mRNA. In control experiments,
DIG-labeled sense RNA probes (®nal concentration, 1 mg per ml) were
used.
Statistics The Dunnett test was used for comparisons between control
and experimental groups (Dunnett, 1964).
RESULTS
Hyaluronan production was increased by IFN-g but
decreased by TGF-b To evaluate whether the cytokines
IFN-g, TGF-b, IL-1a, TNF-a, IL-8, and IL-10 affect the
hyaluronan synthesis of keratinocytes, we added 10 ng per ml of
each cytokine with [3H]glucosamine to the medium and cultured
them for 18 h. Compared to nontreated cells, IFN-g-treated cells
exhibited a 3.5-fold increment in hyaluronan synthesis, whereas
TGF-b-treated cells exhibited a 50% reduction (Fig 1). None of
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the other cytokines, however, had any marked effects on
hyaluronan synthesis. We further examined keratinocyte
hyaluronan synthesis at several concentrations of IFN-g and
TGF-b. The amount of newly synthesized hyaluronan released
into the culture medium after IFN-g addition was signi®cantly
increased in a dose-dependent manner from 1.0 ng per ml to 10 ng
per ml (Fig 2A). In contrast, TGF-b suppressed hyaluronan
synthesis at concentrations above 0.3 ng per ml, and 1.0 ng per
ml TGF-b gave a plateau response (Fig 2B). The results were
con®rmed by a direct measurement of accumulated hyaluronan in
the media (Table I), which corresponded well with the change in
[3H]glucosamine incorporation into hyaluronan (Fig 2).
Under these conditions, the addition of IFN-g or TGF-b at
concentrations of 1.0 ng per ml and 10 ng per ml did not induce
notable alterations in the total cell count or corni®ed cell count
(Table II), indicating that the effects of these cytokines on
hyaluronan synthesis were independent of cell proliferation and
differentiation.
Gel chromatography was used to estimate the effects of IFN-g
and TGF-b on the size distribution of hyaluronan synthesized by
cultured human keratinocytes. Hyaluronan fractions eluted from a
DE-52 anion-exchange column were pooled and passed through a
Sepharose CL-2B column (Fig 3). The puri®ed hyaluronan from
conditioned media of cytokine-stimulated or nonstimulated
keratinocytes was mainly eluted in void fraction (> 1 3 106 Da),
indicating that both IFN-g and TGF-b induced the synthesis of
high-molecular-mass hyaluronan.
HAS3 mRNA level was upregulated by IFN-g but
downregulated by TGF-b To investigate which of the
known members of the HAS family are regulated by IFN-g or
TGF-b, total RNA extracted from keratinocytes stimulated with
IFN-g or TGF-b was examined by northern blot analysis. HAS3
mRNA appeared as two differently sized species, i.e., a major
transcript of approximately 4.9 kb and a minor transcript of 2.0 kb.
When keratinocytes were treated with IFN-g for 6 h, HAS3
Figure 1. Effects of cytokines on hyaluronan synthesis in cultured
human keratinocytes. Con¯uent human keratinocytes were incubated
in the absence or presence of IL-1a (10 ng per ml), TNF-a (10 ng per
ml), IL-8 (10 ng per ml), IL-10 (10 ng per ml), IFN-g (10 ng per ml),
or TGF-b (10 ng per ml) with [3H]glucosamine. The incorporation of
[3H]glucosamine into hyaluronan during the 18 h incubation period was
determined as described in Materials and Methods. Each column represents
the mean 6 SD of four separate experiments. *Signi®cantly different
from the control value; p < 0.01.
Figure 2. The hyaluronan synthesis of human keratinocytes was upregulated by IFN-g but downregulated by TGF-b in a dose-
dependent manner. Con¯uent human keratinocytes were incubated with fresh medium for 24 h followed by cultivating with [3H]glucosamine and
various concentrations of IFN-g (1±30 ng per ml) or TGF-b (0.3±10 ng per m) for 18 h. The incorporation of [3H]glucosamine into hyaluronan was
determined as described in Materials and Methods. Each column represents the mean 6 SD of four separate experiments. *Signi®cantly different from
the control value; p < 0.01.
Table I. Effects of IFN-g and TGF-b on hyaluronan
production
Treatment
Concentration
(ng per ml)
Hyaluronan productiona
(ng per well)
Control 0 126 6 9
IFN-g 1 185 6 34*
10 473 6 14*
TGF-b 1 64 6 5*
10 64 6 4*
aKeratinocytes were grown in the same conditions as for Fig 2. Hyaluronan
content was measured as described in Materials and Methods. The data represent
means 6 SD of four separate experiments.
*Signi®cantly different from the control value; p < 0.01.
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mRNA levels increased markedly and dose dependently (Fig 4A).
On the other hand, TGF-b decreased HAS3 transcript levels
(Fig 4B).
In contrast to the dramatic regulation of HAS3 mRNA by these
cytokines, the expression of 2.4 kb HAS1 mRNA was slightly
upregulated by TGF-b (Fig 4B) and was entirely unaffected by
IFN-g (Fig 4A). We were unable to detect HAS2 mRNA
expression under either basal or cytokine-stimulated conditions
by northern blot analysis using total RNA. To con®rm the
expression of HAS2 mRNA in keratinocytes, poly(A)+ RNA
prepared from keratinocytes was subjected to northern blot analysis,
and it was compared with that from human skin ®broblasts, which
abundantly express HAS2 mRNA (Sugiyama et al, 1998; Zhang et
al, 2000). HAS2 mRNA transcripts of approximately 3.2 and
4.8 kb were detected in cultured skin ®broblasts, but as a trace of
bands in keratinocytes. With overexposure to X-ray ®lm, the
HAS2 mRNA transcripts became detectable as weak signals in
keratinocytes (Fig 4C).
HAS3 mRNA is expressed in epidermis We evaluated the
constitutive expression of HAS3 mRNA in mouse epidermis by in
situ mRNA hybridization (Fig 5A). In epidermis, HAS3 mRNA
was abundantly expressed in the basal to granular cell layers, and
stronger signals were observed in the stratum granulosum. In dermis,
®broblasts also expressed the HAS3 mRNA. The DIG-labeled
sense RNA probe showed a low background (Fig 5B), indicating
that the signals derived from the DIG-labeled HAS3 antisense
RNA probe were speci®c.
DISCUSSION
Although a family of hyaluronan synthases has been identi®ed, the
precise regulatory mechanism of each HAS is still unknown. We
demonstrated that the levels of HAS3 mRNA regulated by IFN-g
and TGF-b corresponded well to the hyaluronan synthesis in
cultured human keratinocytes.
Our in situ hybridization study clearly demonstrated that HAS3
mRNA was abundantly expressed in epidermis. Though hyalur-
onan has been thought to reside exclusively in the basal to spinous
cell layers, we detected strong signals of HAS3 mRNA in the
stratum granulosum. This result accords well with our recent ®nding
that hyaluronan resides not only in the basal to the upper spinous
cell layers but also in the stratum corneum (Sakai et al, 2000),
suggesting that synthesized hyaluronan by keratinocytes is trans-
ferred to the stratum corneum.
The signals of HAS3 mRNA were detected in mouse dermis.
We con®rmed the expression of HAS1, HAS2, and HAS3 genes
using an RNase protection assay in mouse dermis separated from
skin (data not shown). Recent quantitative study of HAS mRNA
levels, however, revealed that no HAS3 mRNA was detected in
Table II. Effects of IFN-g and TGF-b on total cell and corni®ed cell number
Treatment Concentration (ng per ml) Total cell number (310±5 cells per well) Corni®ed cell numbera (310±5 cells per well)
Control 0 4.86 6 0.34 1.33 6 0.25
IFN-g 1 4.58 6 0.46 1.56 6 0.18
10 4.56 6 0.57 1.18 6 0.18
TGF-b 1 4.48 6 0.71 1.32 6 0.11
10 4.38 6 0.66 1.30 6 0.21
aKeratinocytes were grown in the same conditions as for Fig 2. The number of corni®ed cells formed in response to calcium ionophore were estimated as described in
Materials and Methods. The results are the means of four wells 6 SD.
Figure 3. Human keratinocytes synthesized high-molecular-mass
hyaluronan under basal or cytokine-stimulated conditions.
Con¯uent human keratinocytes were incubated with [3H]glucosamine
only (open circles), [3H]glucosamine and IFN-g (10 ng per ml) (closed
triangles), or [3H]glucosamine and TGF-b (10 ng per m) (closed circles) for
18 h. Hyaluronan in media fractions was puri®ed using DE-52 ion-
exchange chromatography and chromatographed using a Sepharose CL-
2B column.
Figure 4. The HAS3 transcript level of human keratinocytes was
upregulated by IFN-g but downregulated by TGF-b in a
dose-dependent manner. Human keratinocytes were cultured in
various concentrations of IFN-g (0±10 ng per ml) (A) or TGF-b (0.3±
3 ng per m) (B) for 6 h and total RNA was extracted. Equal amounts of
samples (5 mg per lane) were hybridized with HAS1 and HAS3 probes.
(C) The level of HAS2 mRNA in cultured human keratinocytes was
lower than that in cultured human skin ®broblasts. Poly(A)+ RNA
extracted from con¯uent cells was used for northern blot analysis. Equal
amounts of samples (2 mg per lane) from ®broblasts and keratinocytes
were hybridized with HAS2 probe and the ®lter was overexposed to X-
ray ®lms. Blots were stripped and rehybridized with a GAPDH probe to
control for variation in loading. Similar results were obtained in two
independent experiments.
46 SAYO ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
the RNA from human skin ®broblasts (Zhang et al, 2000), and we
also obtained the same results by northern blot in our culture
system. One possible explanation for the difference could be a
divergence between species.
When we probed the factors modulating hyaluronan synthesis
from cytokines to evaluate the regulation of the HAS mRNA level
in keratinocytes, we discovered that IFN-g increased the
keratinocyte hyaluronan synthesis, whereas TGF-b decreased it.
This assay was carried out with con¯uent cells under a serum-free
and low-Ca2+ (0.1 mM) condition in which the keratinocytes were
already in a growth-arrest stage or an early stage of differentiation.
The effects of these cytokines on hyaluronan production were
independent of cell number or corni®ed envelope formation. IFN-
g and TGF-b have opposite effects on diverse cellular functions
(Czarniecki et al, 1988; Bauvois et al, 1992; Letterio and Roberts,
1998). The addition of IFN-g to keratinocyte cultures resulted in a
dramatic upregulation of HAS3 mRNA. Conversely, the addition
of TGF-b resulted in a downregulation of HAS3 transcript levels.
IFN-g failed to regulate the HAS1 mRNA level, but TGF-b
slightly upregulated this expression. Our previous study showed
that the TGF-b-induced accumulation of HAS1 mRNA in
cultured keratinocytes was rapid but transient (Sugiyama et al,
1998). Thus, we assumed that HAS1 does not contribute to the
hyaluronan accumulation in the culture medium.
The distinct functional roles of each mammalian HAS protein are
not fully understood. A recent analysis of the size of hyaluronan
molecules generated in an in vitro system by various types of HAS-
expressed COS-1 cells showed that membrane preparations of
HAS2 protein synthesized hyaluronan of signi®cantly higher
molecular mass than that synthesized using HAS3 (3 3 105 Da
to > 2 3 106 Da vs < 2 3 105 Da to »3 3 105 Da) (Spicer and
McDonald, 1998). We showed that human keratinocytes synthe-
sized high-molecular-mass hyaluronan (> 1 3 106 Da) under
either basal or cytokine-stimulated conditions. The polymer size of
synthesized hyaluronan differs between cell-free and cell-cultured
systems. This size can be regulated not only by HAS proteins but
also by other regulatory proteins such as a hyaluronan degradation
protein, as well accessory proteins.
IFN-g, a major cytokine released by activated T lymphocytes
found at elevated levels in hyperproliferative diseases, upregulated
the keratinocyte hyaluronan synthesis. IFN-g is known to stimulate
keratinocyte proliferation by inducing the expression of TGF-a
(Nickoloff et al, 1989).
TGF-b, a cytokine with signi®cant potential for modulation of
connective tissue wound healing, has been reported to stimulate the
production of matrix proteins such as ®bronectin and collagen
(Ignotz and Massagu, 1986; Roberts et al, 1986). In studies using
cultured human skin ®broblasts, we have shown that TGF-b
upregulates HAS1 and HAS2 mRNA (Sugiyama et al, 1998) and
also increases the synthesis of hyaluronan (data not shown). In
contrast, we demonstrated here that TGF-b decreased hyaluronan
synthesis and downregulated the expression of HAS3 mRNA in
cultured human keratinocytes. These results indicate that HAS
genes differentially respond to TGF-b in the dermis and epidermis,
respectively. TGF-b often has opposite effects on cell types within a
given organ. In the skin, in vitro studies have shown that TGF-b
induces proliferation of dermal ®broblasts (Soma and Grotendorst,
1989; Jutley et al, 1993) but arrests growth of epidermal
keratinocytes (Shipley et al, 1986). TGF-b is constitutively
expressed in the basal layer and under basal proliferating conditions
in cultured keratinocytes (Fowlis et al, 1992; Escherick et al, 1993),
suggesting the involvement of TGF-b in a negative feedback
growth regulatory loop. Thus, we postulate that TGF-b may
regulate the proliferation of keratinocytes directly, and also
indirectly by modulating hyaluronan synthesis through HAS3
mRNA expression.
We examined the HAS2 mRNA expression in cultured
keratinocytes, but it was so low that the transcripts were dif®cult
to estimate by northern blot. Our previous study, however, has
shown that HAS2 mRNA was abundantly expressed in mouse
epidermis using in situ mRNA hybridization (Sugiyama et al, 1998),
and a more recent study showed that HAS2 mRNA was expressed
constitutively in a rat keratinocyte cell line and was induced by
EGF (Pienimaki et al, 2001). We cultured the keratinocytes in the
presence of hydrocortisone (180 ng per ml), as in subcultures it
makes the colony morphology more orderly and distinctive
(Rheinwald and Green, 1975). Hydrocortisone is known to be a
suppression factor of hyaluronan synthesis in keratinocytes and in
other cells (Wells et al, 1992; Asplund and Heldin, 1994; AÊ gren et
al, 1995), and HAS2 gene expression was strongly suppressed in
response to glucocorticoids by mesothelial cells, ®broblasts, and
osteosarcoma (Jacobson et al, 2000; Zhang et al, 2000). When
hydrocortisone was depleted from the culture media, HAS1 and
HAS3 transcript levels were increased, but upregulation of HAS2
mRNA was not observed by northern blot using poly(A)+ RNA
(T. Sayo, unpublished data). On this basis, in cultured human
keratinocytes, HAS2 does not contribute substantially to the
hyaluronan accumulation regardless of the presence of hydro-
cortisone under the experimental conditions.
In conclusion, we found that IFN-g and TGF-b had opposite
effects on hyaluronan production in cultured human keratinocytes,
which corresponded to the pattern of keratinocyte HAS3 mRNA
Figure 5. HAS3 mRNA is expressed in mouse skin. Skin specimens from 10-wk-old male hairless mice were analyzed by in situ hybridization.
The following DIG-labeled mouse HAS3 RNA probes were used: (A) DIG-labeled antisense RNA probe; (B) DIG-labeled sense RNA probe. Results
shown are taken from one representative experiment repeated twice.
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expression. The expression of HAS3 mRNA may play a crucial
role in the regulation of hyaluronan synthesis in the epidermis.
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